Skip to content

High fibre diet and low dose lincomycin for chronic constipation

A controlled pilot study on the efficacy of a high fibre diet and a low dose lincomycin for chronic constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33023013
Enrollment
30
Registered
2011-02-16
Start date
1996-09-05
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation Digestive System Constipation

Interventions

The study design determined a 15-day run-in phase without any drug or rescue laxatives and a 21-day controlled treatment period. On the first day of the controlled treatments period (Day 0) enrolled p

Sponsors

Institute of Gastroenterology (Instituto de Gastroenterologia) (Argentina)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet Rome II diagnostic criteria for chronic constipation characterised by: 1.1. A frequency of less than or equal to two bowel movements/week 1.2. Hard stool 1.3. Straining with occasional pain in more than 25% of bowel movements 2. Aged over 18 years, either sex

Exclusion criteria

Exclusion criteria: 1. Cardiac, pulmonary, renal, liver failure 2. Abnormal blood chemistries 3. Known antibiotic allergies In patients who were younger than 50 years and had no other complaint than chronic constipation and the physical examination and routine body chemistries were normal, it was assumed the diagnostic of functional constipation and no special gastrointestinal exams were performed. Patients greater than or equal to 50 years or with lower gastrointestinal bleeding underwent colon radiology or colonoscopy to rule out organic colorectal disease.

Design outcomes

Primary

MeasureTime frame
Difference between treatments in the mean bowel frequency, straining, stool consistency and pain during defecation at baseline (Day 0) and by the end of treatment period (Day 21).

Secondary

MeasureTime frame
No secondary outcome measures

Countries

Argentina

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026